QUIXFEDA Trademark

Trademark Overview

On Friday, March 4, 2022, a trademark application was filed for QUIXFEDA with the United States Patent and Trademark Office. The USPTO has given the QUIXFEDA trademark a serial number of 97297050. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, September 19, 2024. This trademark is owned by AcelRx Pharmaceuticals, Inc.. The QUIXFEDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of cardio-vascular disorders, hypotension, and disorders arising in the course or as a result of general anesthesia
quixfeda

General Information

Serial Number97297050
Word MarkQUIXFEDA
Filing DateFriday, March 4, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2023

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment of cardio-vascular disorders, hypotension, and disorders arising in the course or as a result of general anesthesia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTALPHERA, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSAN MATEO, CA 94404
Party NameAcelRx Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHayward, CA 94545
Party NameAcelRx Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHayward, CA 94545

Trademark Events

Event DateEvent Description
Tuesday, March 8, 2022NEW APPLICATION ENTERED
Wednesday, March 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 15, 2022ASSIGNED TO EXAMINER
Wednesday, December 21, 2022NON-FINAL ACTION WRITTEN
Wednesday, December 21, 2022NON-FINAL ACTION E-MAILED
Wednesday, December 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 21, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, March 21, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, June 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 1, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 1, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 16, 2024SOU EXTENSION 1 FILED
Tuesday, January 16, 2024SOU EXTENSION 1 GRANTED
Thursday, January 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 5, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, September 19, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 19, 2024SOU EXTENSION 2 FILED
Thursday, September 19, 2024SOU EXTENSION 2 GRANTED
Thursday, September 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

quixfeda disorders course result general anesthesia arising hypotension treatment cardio vascular